[{"post_id":"v-69f70237-124f-3ea9-acd0-fc922af945e2_c-16f05b4f-4866-3b3b-af22-9aa5b85d8053_a-3ac2ccce-d4e9-3e33-82e0-7fcfdcf9b6d9","post_url":"https:\/\/www.yahoo.com\/newsroom\/vibes\/world-news\/oncolytics-biotech-r-presents-positive-jcgcqrl","author":"DeltaBravo","provider":"Marketwired","lead_attribution":"provider","link":"https:\/\/finance.yahoo.com\/news\/oncolytics-biotech-r-presents-positive-110000594.html","imgresolutions":null,"img":null,"imgw":null,"imgh":null,"title":"Oncolytics Biotech(R) Presents Positive REOLYSIN(R) Data in Combination with Keytruda and anti-CD73 at International Oncolytic Virus Conference 2018","summary":"Oncolytics Biotech\u00ae Inc. , currently developing REOLYSIN\u00ae , an intravenously delivered immuno-oncolytic virus creating an inflamed phenotype, today announced that a poster highlighting the effectiveness ...","published_at":1523358029,"content_id":"3ac2ccce-d4e9-3e33-82e0-7fcfdcf9b6d9","content_url":"https:\/\/finance.yahoo.com\/news\/oncolytics-biotech-r-presents-positive-110000594.html","content_published_at":1523358000,"content_time":1523358000,"content_relative_time":5,"reaction_count":0,"vibe_name":"World News","vibe_id":"69f70237-124f-3ea9-acd0-fc922af945e2","content_type":"link","aspect":null}]